Clean Yield Group Sells 150,568 Shares of Smith & Nephew plc (NYSE:SNN)

Clean Yield Group reduced its position in Smith & Nephew plc (NYSE:SNN - Free Report) by 80.8% during the first quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 35,846 shares of the medical equipment provider's stock after selling 150,568 shares during the period. Clean Yield Group's holdings in Smith & Nephew were worth $1,017,000 at the end of the most recent quarter.

Other large investors also recently modified their holdings of the company. Principal Securities Inc. lifted its holdings in shares of Smith & Nephew by 87.6% in the 4th quarter. Principal Securities Inc. now owns 1,480 shares of the medical equipment provider's stock worth $36,000 after purchasing an additional 691 shares in the last quarter. National Bank of Canada FI lifted its holdings in shares of Smith & Nephew by 36.5% in the 4th quarter. National Bank of Canada FI now owns 1,667 shares of the medical equipment provider's stock worth $41,000 after purchasing an additional 446 shares in the last quarter. Hara Capital LLC lifted its holdings in shares of Smith & Nephew by 391.4% in the 4th quarter. Hara Capital LLC now owns 2,457 shares of the medical equipment provider's stock worth $60,000 after purchasing an additional 1,957 shares in the last quarter. Versant Capital Management Inc lifted its holdings in shares of Smith & Nephew by 1,970.2% in the 1st quarter. Versant Capital Management Inc now owns 5,217 shares of the medical equipment provider's stock worth $148,000 after purchasing an additional 4,965 shares in the last quarter. Finally, Quadrant Capital Group LLC lifted its holdings in shares of Smith & Nephew by 37.4% in the 4th quarter. Quadrant Capital Group LLC now owns 7,431 shares of the medical equipment provider's stock worth $183,000 after purchasing an additional 2,024 shares in the last quarter. 25.64% of the stock is currently owned by institutional investors.

Analysts Set New Price Targets

SNN has been the subject of a number of analyst reports. UBS Group lowered Smith & Nephew from a "buy" rating to a "neutral" rating in a research report on Wednesday, March 12th. HSBC lowered Smith & Nephew from a "buy" rating to a "hold" rating in a research report on Friday, April 25th. Wall Street Zen raised Smith & Nephew from a "buy" rating to a "strong-buy" rating in a research report on Wednesday, February 26th. Canaccord Genuity Group increased their price target on Smith & Nephew from $27.00 to $28.00 and gave the company a "hold" rating in a research report on Thursday, May 1st. Finally, Hsbc Global Res lowered Smith & Nephew from a "strong-buy" rating to a "hold" rating in a research report on Friday, April 25th. Six research analysts have rated the stock with a hold rating and one has given a strong buy rating to the company's stock. Based on data from MarketBeat, the company currently has an average rating of "Hold" and a consensus target price of $28.00.

Smith & Nephew Trading Down 0.1%

Shares of Smith & Nephew stock opened at $30.28 on Friday. Smith & Nephew plc has a 1 year low of $23.69 and a 1 year high of $31.72. The firm has a market cap of $13.26 billion, a PE ratio of 14.02, a P/E/G ratio of 1.26 and a beta of 0.68. The stock has a fifty day moving average price of $27.62 and a 200-day moving average price of $26.69. The company has a debt-to-equity ratio of 0.63, a current ratio of 2.51 and a quick ratio of 1.11.

Smith & Nephew Company Profile

Smith & Nephew plc engages in the development, manufacture, marketing, and sale of medical devices. It operates through the following segments: Orthopaedics, Sports Medicine and ENT, and Advanced Wound Management. The Orthopaedics and Sports Medicine and ENT segment consists of the following businesses: knee implants, hip implants, other reconstruction, trauma, sports medicine joint repair, arthroscopic enabling technologies, and ENT.

Want to see what other hedge funds are holding SNN? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Smith & Nephew plc (NYSE:SNN - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.